Human bone has an inherent capability to heal itself when injured or broken by creating an electrical field naturally. Bone growth stimulators are used in cases of delay or failure of fracture healing as they enhance the bone healing process without the sensation of electrical shocks or currents or vibrations when worn by the user.
An internal bone growth stimulator or invasive bone growth stimulator is implanted on the fusion site of the bone and it delivers small electrical currents. The internal bone growth stimulator is removed from the body after 6–12 months. An advantage of internal bone growth stimulators is 100% patient compliance, but its disadvantage is that even though the implant is affordable, the double surgery required in the implantation and removal of implant leads to considerable costs. External bone growth stimulator or non-invasive bone growth stimulators are portable devices worn externally and do not require surgical implantation. An external bone growth stimulator is prescribed for use for two to nine hours every day for around three to nine months. An advantage of non-invasive bone growth stimulators is that it is a comparatively less expensive than invasive bone growth stimulator and does not involve surgeries. However, a disadvantage is that there is less patient compliance.
Economic factors such as improvement in service sector, increase in personal income and increase in per capita healthcare expenditure are expected to drive market growth globally. Captivating product features, expanding application in the sports medicine industry, high disability cost payments, among others, are fuelling growth of the global bone growth stimulators market.
The bone growth stimulators market is segmented as follows:
By product By application By end user By region
This report covers the global bone growth stimulators market performance in terms of revenue contribution. The report also also includes FMI’s analysis of key trends, drivers, restraints and opportunities that are influencing the global bone growth stimulators market currently. Impact analysis of key growth drivers and restraints is included in this report to better equip clients with crystal-clear decision-making insights.
By product, the global bone growth stimulators market is segmented into invasive bone growth stimulators, non-invasive bone growth stimulators and ultrasound bone growth stimulators. The non-invasive bone growth stimulators product segment—which comprises capacitive coupling devices, combined magnetic field devices and pulsed ultrasound magnetic field devices-accounts for the highest market share currently and is expected to remain the leading segment in terms of value during the forecast period.
In terms of application segmentation, trauma injury and fractures segment is expected to expand at the highest CAGR in terms of value and volume over the forecast period as compared to other applications. This segment is also expected to represent a major share, both in terms of value and volume, in the global market.
Hospitals end user segment, though projected to account for the highest market share, is expected to expand at an average CAGR in terms of value and volume over the forecast period. Orthopedic clinics and home care end user segments are expected to represent significant market attractiveness indices over the forecast period.
By region, North America is expected to remain the market leader in the bone growth stimulators market mainly due to consumer awareness about chronic pain related to bone fracture and injury and subsequent disability costs. Western Europe is the second-largest contributor to the global market in terms of value and volume owing to availability of public health systems and subsidies, coupled with reliance of patients on the Internet to research about new technologies, such as bone growth stimulators. MEA is projected to expand at a significant pace mainly due to large (particularly expatriate) population, improvements in life expectancy and decline in mortality rates, combined with increased budgetary spend on healthcare, resulting in a major shift and boost in the growth of the bone growth stimulators market in the region. The MEA bone growth stimulators market is still untapped, so companies have substantial growth opportunities in this region.
Key market players covered in this report are DJO LLC, Orthofix International N.V., Zimmer Biomet Holdings Inc., Elizur, Bioventus LLC., Ossatec Benelux BV, Verve Consulting Inc. and IGEA S.p.A. Major players in the bone growth stimulators market are focusing on enhancing their global and regional presence through strategic mergers & acquisitions and operational expansion.
Key Segments Covered
Product Type Non-Invasive Electrical Bone Growth Stimulators Capacitive Coupling (CC) devices Pulsed Electromagnetic Field (PEMF) devices Invasive Electrical Bone Growth Stimulators Ultrasound Bone Growth Stimulators End User Hospital 500+ beds 200–499 beds Less than 200 beds Ambulatory Surgical Centres Orthopaedic Clinics Home Care Application Trauma Injury and Fractures Spinal Fusion Osteogenesis
Key Regions/Countries Covered North America U.S. Canada Latin America Brazil Mexico Rest of Latin America Western Europe U.K. France Germany Spain Italy Rest of Western Europe Eastern Europe Poland Russia Rest of Eastern Europe Asia Pacific Excluding Japan (APEJ) China India Australia and New Zealand Rest of APEJ Japan Middle East & Africa GCC countries South Africa Rest of MEA
Our reports have been used by over 10K customers, including:
The global digital health market reached a value of US$ 289 Billion in 2021. Looking forward, the analyst expects the market to reach US$ 881 Billion by 2027, exhibiting a CAGR of 20.14% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this U.S. Workplace Stress Management Market Report The U.S. workplace stress management market by revenue is expected to grow at a CAGR of 8.25% during the period 2022–2027. The pandemic aggravated stress, driving demand for therapeutic intervention...
122 pages •
By Euromonitor International
• Dec 2021
Consumer health will observe continuing growth in 2021, albeit slightly slowed from the previous year’s growth, as healthcare continues to be a key focus of consumers during the COVID-19 pandemic. The continued growth is despite the challenging economic environment in the country (due to measures taken to control the spread of the virus),...
274 pages •
By Global Industry Analysts
• Jan 2022
Abstract: Global DNA Sequencing Market to Reach US$10.1 Billion by the Year 2026 Deoxyribonucleic acid (DNA) sequencing involves process of determining sequence of four nucleotides bases namely, adenine, cytosine, guanine, and thymine present in DNA. The advanced technology assists healthcare...
The global venture capital investment market reached a value of US$ 211.3 Billion in 2021. Looking forward, the analyst expects the market to reach US$ 584.4 Billion by 2027, exhibiting a CAGR of 20.1% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect...
Report Scope: The report has been prepared in a simple format that can be easily understood with a wealth of tables and charts/figures. The scope of the report includes a detailed study of global and regional markets for various types of adhesives and sealants, with the reasons given for variations in the growth of the...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Fax Services Market Report The fax services market by revenue is expected to grow at a CAGR of 11.03% during the period 2022–2027. Fax services have evolved significantly over the past two decades, and organizations are still using around...
The microwave devices market is projected to grow from USD 6.7 billion in 2021 to USD 9.0 billion by 2027; it is expected to grow at a CAGR of 5.1% from 2021 to 2027. The high usage of active microwave devices in various defense and space electronics has led to the segment’s growth.Active devices are widely used for detecting, mixing, amplifying,...
The global cold plasma market size is expected to reach USD 3.3 billion by 2026 from USD 1.6 billion in 2021, at a CAGR of 15.0% during the forecast period. The growth in this market is primarily attributed to the benefits of cold plasma, such as its environment-friendliness, increasing use of cold plasma in wound healing and cancer treatment,...
The global alopecia treatment market exhibited moderate growth during 2015-2020. Looking forward, the analyst expects the market to grow at a CAGR of around 5% during 2021-2026. Alopecia, also known as hair loss, is an autoimmune skin disease affecting the growth of healthy hair follicles on the scalp, face,...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.